Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth M Pfeiffer

Showing results (61-70 of 554) with videos related to

Pageof 56
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2011
The association of telomere length and cancer: a meta-analysisIngrid M Wentzensen, Lisa Mirabello, Ruth M Pfeiffer, et al.
Breast Cancer Research and Treatment|February 17, 2018
Lipid-lowering drugs, dyslipidemia, and breast cancer risk in a Medicare populationCatherine Schairer, D Michal Freedman, Shahinaz M Gadalla, et al.
Hepatology (Baltimore, Md.)|October 17, 2015
No scientific basis to restrict 8 weeks of treatment with ledipasvir/sofosbuvir to patients with hepatitis C virus RNA <6,000,000 IU/mLThomas R O'Brien, Jordan J Feld, Shyam Kottilil, et al.
International Journal of Cancer|May 28, 2022
Immune-related conditions and cancer-specific mortality among older adults with cancer in the United StatesJeanny H Wang, Andriy Derkach, Ruth M Pfeiffer, et al.
Statistics in Medicine|April 12, 2024
Mediation analysis using incomplete information from publicly available data sourcesAndriy Derkach, Elizabeth D Kantor, Joshua N Sampson, et al.
Plos One|December 14, 2023
Frequentist model averaging for analysis of dose-response in epidemiologic studies with complex exposure uncertaintyDeukwoo Kwon, Steven L Simon, F Owen Hoffman, et al.
Journal of the National Cancer Institute|May 15, 2008
Racial differences in breast cancer trends in the United States (2000-2004)Ruth M Pfeiffer, Aya Mitani, Rayna K Matsuno, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics|March 17, 2025
Building absolute breast cancer risk prediction models for women treated with chest radiation for Hodgkin lymphomaSander Roberti, Flora E van Leeuwen, Michael Hauptmann, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 3, 2018
Proportion of U.S. Trends in Breast Cancer Incidence Attributable to Long-term Changes in Risk Factor DistributionsRuth M Pfeiffer, Yenny Webb-Vargas, William Wheeler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2010
Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy eraEric A Engels, Ruth M Pfeiffer, Ola Landgren, et al.
Pageof 56

Showing results (61-70 of 554) with videos related to

Sort By:
Pageof 56
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2011
The association of telomere length and cancer: a meta-analysisIngrid M Wentzensen, Lisa Mirabello, Ruth M Pfeiffer, et al.
Breast Cancer Research and Treatment|February 17, 2018
Lipid-lowering drugs, dyslipidemia, and breast cancer risk in a Medicare populationCatherine Schairer, D Michal Freedman, Shahinaz M Gadalla, et al.
Hepatology (Baltimore, Md.)|October 17, 2015
No scientific basis to restrict 8 weeks of treatment with ledipasvir/sofosbuvir to patients with hepatitis C virus RNA <6,000,000 IU/mLThomas R O'Brien, Jordan J Feld, Shyam Kottilil, et al.
International Journal of Cancer|May 28, 2022
Immune-related conditions and cancer-specific mortality among older adults with cancer in the United StatesJeanny H Wang, Andriy Derkach, Ruth M Pfeiffer, et al.
Statistics in Medicine|April 12, 2024
Mediation analysis using incomplete information from publicly available data sourcesAndriy Derkach, Elizabeth D Kantor, Joshua N Sampson, et al.
Plos One|December 14, 2023
Frequentist model averaging for analysis of dose-response in epidemiologic studies with complex exposure uncertaintyDeukwoo Kwon, Steven L Simon, F Owen Hoffman, et al.
Journal of the National Cancer Institute|May 15, 2008
Racial differences in breast cancer trends in the United States (2000-2004)Ruth M Pfeiffer, Aya Mitani, Rayna K Matsuno, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics|March 17, 2025
Building absolute breast cancer risk prediction models for women treated with chest radiation for Hodgkin lymphomaSander Roberti, Flora E van Leeuwen, Michael Hauptmann, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 3, 2018
Proportion of U.S. Trends in Breast Cancer Incidence Attributable to Long-term Changes in Risk Factor DistributionsRuth M Pfeiffer, Yenny Webb-Vargas, William Wheeler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2010
Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy eraEric A Engels, Ruth M Pfeiffer, Ola Landgren, et al.
Pageof 56